Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
Department of Laboratory Medicine, Lund University, Lund, Sweden; Lund Stem Cell Center, Lund University, Lund, Sweden.
deCODE Genetics/Amgen, Reykjavik, Iceland.
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
Show others and affiliations
2024 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 15, no 1, article id 6644Article in journal (Refereed) Published
Abstract [en]

Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in a genome-wide association study totaling 10,906 cases and 366,221 controls, we identify 35 MM risk loci, 12 of which are novel. Through functional fine-mapping and Mendelian randomization, we uncover two causal mechanisms for inherited MM risk: longer telomeres; and elevated levels of B-cell maturation antigen (BCMA) and interleukin-5 receptor alpha (IL5RA) in plasma. The largest increase in BCMA and IL5RA levels is mediated by the risk variant rs34562254-A at TNFRSF13B. While individuals with loss-of-function variants in TNFRSF13B develop B-cell immunodeficiency, rs34562254-A exerts a gain-of-function effect, increasing MM risk through amplified B-cell responses. Our results represent an analysis of genetic MM predisposition, highlighting causal mechanisms contributing to MM development.

Place, publisher, year, edition, pages
Springer Nature, 2024. Vol. 15, no 1, article id 6644
National Category
Medical Genetics and Genomics Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-228486DOI: 10.1038/s41467-024-50932-7ISI: 001284820100008PubMedID: 39103364Scopus ID: 2-s2.0-85200470126OAI: oai:DiVA.org:umu-228486DiVA, id: diva2:1889693
Funder
Swedish Cancer Society, 200696Swedish Research Council, 2017-02023Swedish Research Council, 2018-00424EU, European Research Council, EU-MSCA-COFUND 754299EU, European Research Council, 847583 CanFasterEU, Horizon 2020, 856620Available from: 2024-08-16 Created: 2024-08-16 Last updated: 2025-04-24Bibliographically approved

Open Access in DiVA

fulltext(2607 kB)52 downloads
File information
File name FULLTEXT01.pdfFile size 2607 kBChecksum SHA-512
925f8a000741877e447d3f55701b3937f8328aa837254c4804f8befad6a2f7fb667ba8894a12f7ea0f9ec4318096f3c4a983408715fd4bae2791e5ed8de92362
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Pettersson-Kymmer, UlrikaSpäth, Florentin

Search in DiVA

By author/editor
Pettersson-Kymmer, UlrikaSpäth, Florentin
By organisation
Department of Integrative Medical Biology (IMB)Department of Radiation Sciences
In the same journal
Nature Communications
Medical Genetics and GenomicsCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 52 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 291 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf